•
Mar 31, 2013

Arrowhead Pharmaceuticals Q2 2013 Earnings Report

Total Revenue
$43.8K
Previous year: $31.3K
+40.0%
EPS
-$0.41
Previous year: -$0.5
-18.0%
Gross Profit
$43.8K
Previous year: $31.3K
+40.0%
Cash and Equivalents
$3.31M
Previous year: $3.6M
-7.8%
Total Assets
$12.4M
Previous year: $20.1M
-38.2%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals